Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexacerfont for methamphetamine dependence withdrawal treatment
IRCT201412031556N69Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pexacerfont in methamphetamine use disorder (MUD) and substance withdrawal, sponsored by Tehran University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
pexacerfont
03
Conditions
methamphetamine use disorder (MUD)substance withdrawal
Beyond the preview
Go deeper on IRCT201412031556N69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201412031556N69.